Harnessing neuroplasticity for clinical applications

Clicks: 3
ID: 297020
2011
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #221 of 375 articles by views in Brain research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 375 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Neuroplasticity can be defined as the ability of the nervous system to respond to intrinsic or extrinsic stimuli by reorganizing its structure, function and connections. Major advances in the understanding of neuroplasticity have to date yielded few established interventions. To advance the translation of neuroplasticity research towards clinical applications, the National Institutes of Health Blueprint for Neuroscience Research sponsored a workshop in 2009. Basic and clinical researchers in disciplines from central nervous system injury/stroke, mental/addictive disorders, paediatric/developmental disorders and neurodegeneration/ageing identified cardinal examples of neuroplasticity, underlying mechanisms, therapeutic implications and common denominators. Promising therapies that may enhance training-induced cognitive and motor learning, such as brain stimulation and neuropharmacological interventions, were identified, along with questions of how best to use this body of information to reduce human disability. Improved understanding of adaptive mechanisms at every level, from molecules to synapses, to networks, to behaviour, can be gained from iterative collaborations between basic and clinical researchers. Lessons can be gleaned from studying fields related to plasticity, such as development, critical periods, learning and response to disease. Improved means of assessing neuroplasticity in humans, including biomarkers for predicting and monitoring treatment response, are needed. Neuroplasticity occurs with many variations, in many forms, and in many contexts. However, common themes in plasticity that emerge across diverse central nervous system conditions include experience dependence, time sensitivity and the importance of motivation and attention. Integration of information across disciplines should enhance opportunities for the translation of neuroplasticity and circuit retraining research into effective clinical therapies.
Reference Key
openalex_W2107022859 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Steven C. Cramer, Mriganka Sur, Bruce H. Dobkin, Charles P. O’Brien, Terence D. Sanger, John Q. Trojanowski, Judith M. Rumsey, Ramona Hicks, Judy L. Cameron, David Chen, Wen Chen, Leonardo G. Cohen, C. deCharms, C. J. Duffy, Guinevere F. Eden, E. E. Fetz, Rosemarie Filart, M C Freund, Steven Grant, Suzanne N. Haber, Peter W. Kalivas, Bryan Kolb, Arthur F. Kramer, Michael P. Lynch, Helen S. Mayberg, Patrick S. McQuillen, Ralph Nitkin, A. Pascual–Leone, Patricia A. Reuter‐Lorenz, Nicholas D. Schiff, Anu Sharma, L. Shekim, Michael P. Stryker, Edith V. Sullivan, Sophia Vinogradov
Journal Brain research
Year 2011
DOI
10.1093/brain/awr039
URL
https://doi.org/10.1093/brain/awr039
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.